Summary of Key Information:

Reporting Period: Quarter ended 30 June 2026 (Q1 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting - Financial Results and Dividend Declaration

Audit Opinion:

Clean opinion - Limited review conducted by B S R and Co Chartered Accountants. No material misstatements identified.

Key Financial Highlights [₹ in Lakhs]:

Standalone Results:

Revenue from Operations: ₹10,568.33 (Q1 FY27) vs ₹8,017.42 (Q1 FY26) - 32% YoY increase

Total Income: ₹11,508.36 (Q1 FY27) vs ₹8,679.38 (Q1 FY26) - 33% YoY increase

Net Profit: ₹3,382.85 (Q1 FY27) vs ₹2,520.49 (Q1 FY26) - 34% YoY increase

EPS: ₹3.00 (Basic and Diluted) for Q1 FY27

Other Equity: ₹77,471.43 (as of 31 March 2026)

Consolidated Results:

Revenue from Operations: ₹15,827.05 (Q1 FY27) vs ₹12,491.75 (Q1 FY26) - 27% YoY increase

Total Income: Not separately specified

Net Profit: ₹4,058.69 (Q1 FY27) vs ₹3,126.92 (Q1 FY26) - 30% YoY increase

EPS: ₹3.59 (Basic) for Q1 FY27

Other Equity: Not specified

Segment-wise Performance [₹ in Lakhs]:

The Group operates in two segments:

Pharmaceutical, Food and Nutrition Segment:

External Revenue: ₹10,841.37 (Q1 FY27) vs ₹8,208.68 (Q1 FY26)

Segment Result: ₹4,002.45 (Q1 FY27) vs ₹2,657.21 (Q1 FY26)

Segment Assets: ₹78,691.31 (as of 30 June 2026)

Speciality Ingredients Segment:

External Revenue: ₹4,985.68 (Q1 FY27) vs ₹4,193.07 (Q1 FY26)

Segment Result: ₹1,088.60 (Q1 FY27) vs ₹1,405.07 (Q1 FY26)

Segment Assets: ₹46,307.39 (as of 30 June 2026)

Corporate Actions:

Interim Dividend: ₹3.59 per equity share of face value ₹1 each for FY27

Other Significant Information:

IPO Proceeds Utilization:

Gross Proceeds: ₹9,500.00 lakhs

Less: Estimated offer expenses borne by Company: ₹666.41 lakhs

Net Proceeds: ₹8,833.59 lakhs

Utilization as of 30 June 2026:

  • Capital expenditure for Nandesari Facility: ₹35.77 lakhs utilized, ₹7,545.63 lakhs unutilized (kept as term deposits)
  • General corporate purposes: ₹1,252.19 lakhs fully utilized
  • Total utilized: ₹1,287.96 lakhs
  • Total unutilized: ₹7,545.63 lakhs

Acquisition Update:

The Group completed final purchase price allocation for its acquisition of 85% equity interest in Nutrition Supplier & Services (Ireland) Limited (NSS) for ₹12,857.63 lakhs. The acquisition was completed on 22 May 2025, and NSS became a step-down subsidiary. Goodwill has been recognized in the unaudited consolidated financial results.